Survey of quality of life, phenotypic expression, and response to treatment in Krabbe leukodystrophy.

dc.contributor.author

Langan, Thomas J

dc.contributor.author

Barczykowski, Amy

dc.contributor.author

Jalal, Kabir

dc.contributor.author

Sherwood, Laura

dc.contributor.author

Allewelt, Heather

dc.contributor.author

Kurtzberg, Joanne

dc.contributor.author

Carter, Randy L

dc.date.accessioned

2022-03-23T15:32:45Z

dc.date.available

2022-03-23T15:32:45Z

dc.date.issued

2019-05

dc.date.updated

2022-03-23T15:32:45Z

dc.description.abstract

Objectives

To develop a quality of life (QOL) survey for Krabbe disease (KD), and to thereby improve understanding of its phenotypic expression and response to treatment.

Methods

The survey, the Leukodystrophy Quality of Life Assessment (LQLA) and the Vineland Adaptive Behavior Scales were co-administered to 33 patients or their caretakers. These included the phenotypes of early infantile KD (EIKD; 0-6 months old at onset), late infantile cases (LIKD; 7-12 months old at onset), and cases that emerged after 12 months old, late onset (LOKD). The sample included cases with and without stem cell transplantation (SCT). Reliability and concurrent validity were assessed for overall and subscale scores. Analysis of variance tested differences in QOL between phenotypes and transplant groups (none, pre-, post-symptom).

Results

Good concurrent validity with the Vineland was shown for total, communication, daily activity, social, and motor scales and good reliability was observed. LOKD cases had better communication skills than either EIKD or LIKD and better overall QOL than EIKD. Analyses of individual items showed that communication items, mostly, contributed significantly to phenotype differences. Presymptomatic SCT significantly improved QOL compared to postsymptomatic SCT or no treatment. Presymptomatically treated patients had near-normal total scores.

Conclusions

The LQLA is valid and reliable. Despite small sample size, phenotypic demarcation was determined to be due mainly to differences in communication skills. There was a relative enhancement of QOL in LOKD patients, and in those who had presymptomatic SCT. These results apply to the current controversy about recommendations for newborn screening for this condition.
dc.identifier

JMD212033

dc.identifier.issn

2192-8304

dc.identifier.issn

2192-8312

dc.identifier.uri

https://hdl.handle.net/10161/24598

dc.language

eng

dc.publisher

Wiley

dc.relation.ispartof

JIMD reports

dc.relation.isversionof

10.1002/jmd2.12033

dc.subject

neurodegeneration

dc.subject

newborn screening

dc.subject

transplantation

dc.title

Survey of quality of life, phenotypic expression, and response to treatment in Krabbe leukodystrophy.

dc.type

Journal article

duke.contributor.orcid

Kurtzberg, Joanne|0000-0002-3370-0703

pubs.begin-page

47

pubs.end-page

54

pubs.issue

1

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Pathology

pubs.organisational-group

Pediatrics

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Initiatives

pubs.organisational-group

Duke Innovation & Entrepreneurship

pubs.organisational-group

Pediatrics, Transplant and Cellular Therapy

pubs.publication-status

Published

pubs.volume

47

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
p352 Langan.pdf
Size:
894.6 KB
Format:
Adobe Portable Document Format
Description:
Published version